Top section
Top section
UzNIF offers cross-section of Uzbek economy in biggest London IPO for five years
Bpifrance pounces to sell Technip block after shares leap
Europe’s self-proclaimed investment banking champions are playing to their strengths, but remain far behind US peers
More articles
More articles
More articles
-
Sino Biopharmaceutical’s chief executive Tse Ping has sold a portion of his stake in the company for the second time this year, pocketing HK$3.15bn ($406.4m) but causing the stock price to tumble in the secondary market. -
The European Commission is looking to change its rules on research unbundling and other aspects of MiFID II to ease the post-coronavirus recovery in the EU. It is also set to present tweaks to rules on securitization and prospectuses.
-
BioNTech, the German biopharmaceuticals company, is selling 5.5m American Depositary Receipts (ADRs) on the Nasdaq through a share sale and a rights issue. The company, which is working with Pfizer to develop a vaccine for Covid-19, is the latest issuer to hit the market in a wave of biotech ECM issuance — but buyers are being warned against being too eager, reports Sam Kerr.
-
Invesco changes fixed interest line-up — BofA makes Slowey equities head — NordLB hires two for DCM
-
Ant Group is planning a dual listing in Hong Kong and Shanghai that will value the company at as much as $200bn. Bankers say the mega listing will be a ‘shot of adrenaline’ for the two stock exchanges, creating a surge of liquidity that will enable more companies to follow suit. Jonathan Breen reports.
-
Asian Development Bank offloaded chunks of Thai energy companies B.Grimm Power and Gulf Energy Development this week, raising Bt9.6bn ($303.9m).
Sub-sections
shared comment list
